Back to Search
Start Over
339TiP A randomized trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer (ARIADNE).
- Source :
-
Annals of Oncology . 2024 Supplement 2, Vol. 35, pS356-S356. 1p. - Publication Year :
- 2024
- Subjects :
- *HER2 positive breast cancer
*NEOADJUVANT chemotherapy
*TRASTUZUMAB
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 35
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 179691697
- Full Text :
- https://doi.org/10.1016/j.annonc.2024.08.278